Bath salts and synthetic cathinones: an emerging designer drug phenomenon. - sprookjes - yvandenbroek - TriplyDB

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

http://www.wikidata.org/entity/Q37540813

about

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.Ethylone-Related Deaths: Toxicological Findings Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Emerging drugs of abuse: current perspectives on substituted cathinones.Administration of high dose of methamphetamine has detrimental effects on sperm parameters and DNA integrity in mice.Mephedrone alters basal ganglia and limbic neurotensin systems.3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.Analysis of a new drug of abuse: cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one.Baths salts, spice, and related designer drugs: the science behind the headlines.The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.Mephedrone alters basal ganglia and limbic dynorphin systems.Synthetic cathinones: a new public health problem 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions.Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives Awareness survey of so-called Dappou drugs or Kiken drugs (New Psychoactive Substances) among University Students in Japan Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs Severe Psychosis, Drug Dependence, and Hepatitis C Related to Slamming Mephedrone.Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.Flakka-Induced Prolonged Psychosis.State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse.Neuropathology of substance use disorders.Nephrotoxic effects of designer drugs: synthetic is not better!Designer drugs and sexual dysfunction.Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes.The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure.Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS.Product ion tandem mass spectrometric differentiation of regioisomeric side-chain groups in cathinone derivatives.Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent.Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.Identification of polymorphism in ethylone hydrochloride: synthesis and characterization.MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.Clinical characteristics of α-pyrrolidinovalerophenone (α-PVP) poisoning.Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?Differentiation of cyclic tertiary amine cathinone derivatives by product ion electron ionization mass spectrometry.Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.Designer drugs: Review and implications for emergency management.Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.

P2860

Q26752739-61AE4478-A67D-442C-A056-3B50A4CDB964 Q27311250-90F27D36-C212-4253-819D-E198D04298D4 Q28262614-A07F9FB7-3BA2-45E6-A499-93872A428A4D Q30148688-1B9FBF6F-D138-4233-BDBB-6F0E1A790F70 Q33706892-4F2F40B9-4739-4A4C-B290-5B1AA2630011 Q33736934-A78D7027-E6DB-4518-92B4-6772CAD91D13 Q33934521-939179F2-2BFC-4757-8431-787B2608D960 Q34115248-D838FF87-1D9E-496E-94A5-1AB174E93BA4 Q34455874-D633EE58-8890-4EAB-89BD-51DE2DF60B51 Q34491601-3A618020-46D0-4E57-B242-94328CD6806F Q34493739-5223FE77-CD11-40B9-823D-7771D27E911D Q35186200-44881455-FFD1-4E72-A754-BEAFF4E7CFE3 Q35710543-378164EF-4AB6-4878-9EC0-B6286A399C85 Q35871216-FB0EA25A-5448-46CD-BBFA-E23ED92BE947 Q35897800-127B1E96-166E-4A0C-9840-1F789C7E568A Q36141074-02C1D5C3-8AE5-402E-8A77-C1597D860BD3 Q36633551-9FA44C32-EA48-4D1D-83FC-B3AE5B832F98 Q36879970-17FCA281-BE0B-43D7-9A57-DDE82FAD038C Q36928167-53461AFF-5FD8-49F2-BDB8-20F9039691E0 Q36986325-B2E4EA52-E68F-49EA-B693-3D6385A1B853 Q37067536-E6AA823A-5044-4555-AF05-F64C103EED52 Q37226593-3A9DD77D-AEB1-4C0F-9587-E4EE71CC1393 Q38167646-5C40507F-150D-40A0-BEB6-8C1D6AA6665C Q38198873-A908EA9B-50FB-4A7B-B06A-930F67DE7CE1 Q38264198-C7237A6F-AA4C-4524-81C8-CB020CD6AD6A Q38333687-5F228C32-A69F-4F7F-8195-84F8A8349292 Q38711064-ACD11AAB-341E-43A7-B9D1-CCBB5CA9A0E2 Q38836231-F75E0F7D-08A0-4415-B401-D36202BBC6A1 Q38887292-AEC6865D-8BEC-4AAB-AC3E-566E7B92B594 Q38966221-06DB5831-F0A6-4EAE-814E-480F47A45D61 Q38973726-D1015C5A-C5D7-4752-963E-D1EE44B805C3 Q38978095-258315AD-8CEF-4831-8111-94A2BB0AA27D Q39134009-9351230A-95C6-42E1-BF04-E4EE8F069AB6 Q39345691-89183E2C-7469-43E5-927F-067C1DF553F4 Q39734763-5BB474BE-23F1-48D0-B990-8B89C154BA01 Q39754020-F2D897B9-8FBE-4216-9963-F274E9687158 Q40006791-1511715E-89C9-4CDE-9BB3-0A0017F4D8E2 Q40054798-0C070702-E605-471E-A146-2CFD7FB74A56 Q40099251-5A7571FB-4FDB-4536-B725-ABAAD29D2A8A Q40436637-0EFCE397-4982-4F9E-843C-18BD5A063D12

P2860

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

http://www.wikidata.org/entity/Q37540813

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@en

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@nl

type

label

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@en

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@nl

prefLabel

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@en

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@nl

P1433

Q37540813-6245A3BF-D191-43ED-9689-57045686C6DD

P1476

Q37540813-B0589C17-F7FA-4C84-B38E-8AAD8A8BBAD0

P2093

Q37540813-0C9CCEE5-8079-47A2-9223-3A25CF5135AC

Q37540813-0F954F16-9369-4AF7-96D6-AEB1A29B008F

Q37540813-B4D4B430-6DB1-488F-B93D-D79C389CE9D8

P2860

Q37540813-0787F9F0-6AB7-4F01-B2DF-ADC59143054A

Q37540813-108F3BF0-4ED4-4548-8A8E-BA5665AC1E22

Q37540813-17D331A6-FC69-46E0-B637-0E31029C07FD

Q37540813-19BBBB2F-6000-49A4-9EE6-08E722BD9FFB

Q37540813-1A0CB44A-D9DB-49A1-8E56-559915CF608F

Q37540813-1E8A6441-5CB9-4E43-9961-2E9D20885621

Q37540813-21032017-AC0F-4368-AB7A-8AD3944A5D96

Q37540813-26D00F5F-B107-47DA-B980-6357B960A719

Q37540813-274DD085-2FC6-4F1A-9FD7-A4C8E415B93B

Q37540813-2AEB2761-ADEC-4D43-B078-89C2DF9624C7

P304

Q37540813-5E15FBEA-A0DA-4813-959E-F871DA209C11

P31

Q37540813-84EA37B6-52D2-436E-9962-7CA037E87B74

P356

Q37540813-ED182AB5-D0DD-4D0A-88E9-EA6D0C75E95A

P407

Q37540813-E52754BA-CBDB-4CD3-87EA-F85078361677

P433

Q37540813-2B7FD00C-A806-4D2F-9EF9-8939D536A418

P478

Q37540813-9FA395C8-A43F-4993-853D-9A8FC072E9F0

P577

Q37540813-DC793DF7-A858-435D-8EA6-5884A802EFF0

P5875

Q37540813-AC425A54-7877-48C3-B19D-5395F5B680C6

P698

Q37540813-119B1348-CBBF-49F3-B80D-8FE99BD37303

P932

Q37540813-C54C5FFC-39A6-467A-A230-08F1C52CDA9C

P356

J.LFS.2013.07.023

P1433

P1476

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

@en

P2093

Annette E Fleckenstein

http://www.w3.org/2001/XMLSchema#string

Christopher L German

http://www.w3.org/2001/XMLSchema#string

Glen R Hanson

http://www.w3.org/2001/XMLSchema#string

P2860

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum

Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse

Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones

The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents

Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)

Behind the identification of China White

P304

2-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.LFS.2013.07.023

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255176413

http://www.w3.org/2001/XMLSchema#string

P698

23911668

http://www.w3.org/2001/XMLSchema#string

P932

3909723

http://www.w3.org/2001/XMLSchema#string